Literature DB >> 11309213

Modern management of the cancer anorexia-cachexia syndrome.

K A Nelson1.   

Abstract

The cancer anorexia-cachexia syndrome is common, occurring in 80% of patients with advanced-stage cancer, and it is one of the most frequent causes of death in patients with cancer. It is a complex problem involving abnormalities in protein, carbohydrate, and fat metabolism. Tumors have both direct and indirect effects that result in anorexia and weight loss. The disease burden does not necessarily correlate with the degree of cachexia. In addition to the physical manifestations, the resulting abnormalities have a significant psychologic effect on patients and their families. Although there is no treatment to reverse the process, pharmacologic and nonpharmacologic measures can enhance food intake and improve quality of life.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309213     DOI: 10.1007/s11916-001-0039-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  32 in total

1.  Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.

Authors:  C L Loprinzi; J W Kugler; J A Sloan; J A Mailliard; J E Krook; M B Wilwerding; K M Rowland; J K Camoriano; P J Novotny; B J Christensen
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

2.  Corticosteroid therapy of preterminal gastrointestinal cancer.

Authors:  C G Moertel; A J Schutt; R J Reitemeier; R G Hahn
Journal:  Cancer       Date:  1974-06       Impact factor: 6.860

Review 3.  Corticosteroids and peptic ulceration.

Authors:  J E Ellershaw; M J Kelly
Journal:  Palliat Med       Date:  1994-10       Impact factor: 4.762

4.  Prednisolone as an appetite stimulant in patients with cancer.

Authors:  J C Willox; J Corr; J Shaw; M Richardson; K C Calman; M Drennan
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07

5.  Assessment of upper gastrointestinal motility in the cancer-associated dyspepsia syndrome.

Authors:  K A Nelson; T D Walsh; F G Sheehan; P B O'Donovan; G W Falk
Journal:  J Palliat Care       Date:  1993       Impact factor: 2.250

6.  Pharmacoeconomics of nutritional support in cancer.

Authors:  N S Tchekmedyian
Journal:  Semin Oncol       Date:  1998-04       Impact factor: 4.929

7.  The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids.

Authors:  J L Carson; B L Strom; R Schinnar; A Duff; E Sim
Journal:  Am J Med       Date:  1991-09       Impact factor: 4.965

Review 8.  The risks and benefits of corticosteroids in advanced cancer.

Authors:  R Twycross
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

9.  Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study.

Authors:  E Bruera; E Roca; L Cedaro; S Carraro; R Chacon
Journal:  Cancer Treat Rep       Date:  1985 Jul-Aug

10.  Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

Authors:  J E Beal; R Olson; L Laubenstein; J O Morales; P Bellman; B Yangco; L Lefkowitz; T F Plasse; K V Shepard
Journal:  J Pain Symptom Manage       Date:  1995-02       Impact factor: 3.612

View more
  1 in total

1.  Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs.

Authors:  Masanori Takahashi; Masanori Terashima; Akinori Takagane; Kenichi Oyama; Hisataka Fujiwara; Go Wakabayashi
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.